{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:51:03Z","timestamp":1771530663014,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1828,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1398-9995.2010.02468.x","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T15:52:12Z","timestamp":1283269932000},"page":"255-263","source":"Crossref","is-referenced-by-count":28,"title":["Treatment with a Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy"],"prefix":"10.1111","volume":"66","author":[{"given":"T.","family":"Saarne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Neimert-Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gr\u00f6nlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jutel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gafvelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"van Hage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,30]]},"reference":[{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1398-9995.1996.tb00043.x","article-title":"Possible induction of food allergy during mite immunotherapy","volume":"51","author":"van Ree","year":"1996","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<2026::AID-IMMU2026>3.0.CO;2-2","article-title":"Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy","volume":"29","author":"Ball","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1034\/j.1398-9995.2002.13248.x","article-title":"Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System","volume":"57","author":"Mov\u00e9rare","year":"2002","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1081-1206(10)62195-3","article-title":"Systemic reactions and fatalities associated with allergen immunotherapy","volume":"87","author":"Lockey","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1046\/j.1365-2222.2002.01544.x","article-title":"Safety of inhalant allergen immunotherapy with mass units-standardized extracts","volume":"32","author":"Nettis","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1056\/NEJMct0708337","article-title":"Sublingual immunotherapy","volume":"358","author":"Frew","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.addr.2004.09.008","article-title":"Immunity in response to particulate antigen-delivery systems","volume":"57","author":"Storni","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2567.2002.01535.x","article-title":"Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy","volume":"107","author":"Gr\u00f6nlund","year":"2002","journal-title":"Immunology"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11882-005-0035-7","article-title":"Immunostimulatory sequences of DNA and conjugates in the treatment of allergic rhinitis","volume":"5","author":"Broide","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaci.2007.01.025","article-title":"Recombinant allergens for immunotherapy","volume":"119","author":"Valenta","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1398-9995.2007.01609.x","article-title":"From allergen genes to new forms of allergy diagnosis and treatment","volume":"63","author":"Vrtala","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaci.2007.02.015","article-title":"Update on the current status of peptide immunotherapy","volume":"119","author":"Larch\u00e9","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymeth.2003.08.016","article-title":"Strategies for converting allergens into hypoallergenic vaccine candidates","volume":"32","author":"Vrtala","year":"2004","journal-title":"Methods"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"40144","DOI":"10.1074\/jbc.M301416200","article-title":"Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli","volume":"278","author":"Gr\u00f6nlund","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2222.2005.02234.x","article-title":"Rational design of hypoallergens applied to the major cat allergen Fel d 1","volume":"35","author":"Saarne","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1398-9995.2008.01644.x","article-title":"Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy","volume":"63","author":"Neimert-Andersson","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1398-9995.2008.01905.x","article-title":"Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice","volume":"64","author":"Thunberg","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1152\/japplphysiol.01389.2003","article-title":"Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness","volume":"97","author":"Hjoberg","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri1934","article-title":"Immunological mechanisms of allergen-specific immunotherapy","volume":"6","author":"Larch\u00e9","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB21|cit21","first-page":"285","article-title":"Isotype-associated recognition of allergen epitopes and its modulation by antigen dose","volume":"84","author":"Kolbe","year":"1995","journal-title":"Immunology"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.molimm.2008.01.006","article-title":"Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering","volume":"45","author":"Chen","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1398-9995.2008.01910.x","article-title":"Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination","volume":"64","author":"Ball","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1096\/fasebj.13.11.1277","article-title":"B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy","volume":"13","author":"Ball","year":"1999","journal-title":"FASEB J"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1172\/JCI117701","article-title":"Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors","volume":"95","author":"Daeron","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.4049\/jimmunol.163.5.2944","article-title":"Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation","volume":"163","author":"van Neerven","year":"1999","journal-title":"J Immunol"},{"key":"10.1111\/j.1398-9995.2010.02468.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0091-6749(03)02022-0","article-title":"Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy","volume":"112","author":"Wachholz","year":"2003","journal-title":"J Allergy Clin Immunol"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2010.02468.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1398-9995.2010.02468.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T02:33:10Z","timestamp":1685759590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2010.02468.x"}},"subtitle":["Hypoallergen treatment in a mouse model for cat allergy"],"short-title":[],"issued":{"date-parts":[[2010,8,30]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2010.02468.x","relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,30]]}}}